Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections

Due to the lack of an effective therapeutic treatment to flavivirus, dengue virus (DENV) nonstructural protein 1 (NS1) has been considered to develop a vaccine owing to its lack of a role in antibody-dependent enhancement (ADE). However, both NS1 and its antibody have shown cross-reactivity to host...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rochanawan Sootichote, Wilarat Puangmanee, Surachet Benjathummarak, Siriporn Kowaboot, Atsushi Yamanaka, Korbporn Boonnak, Sumate Ampawong, Supawat Chatchen, Pongrama Ramasoota, Pannamthip Pitaksajjakul
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-01-01
coleção:	Biomedicines
Assuntos:	dengue virus Zika virus dengue non-structural protein 1 human monoclonal antibody neutralization vascular leakage
Acesso em linha:	https://www.mdpi.com/2227-9059/11/1/227
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!